Navidea Biopharmaceuticals, Inc. Announces Extension of Authority to Implement a Reverse Stock Split

• click to rate

  Posted by Two Blokes May 21, 2025 - Filed in Stock - 5 views
  
  COLUMBUS, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (OTC: NAVB) (“Navidea” or the “Company”), a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the extension of its authority to implement a reverse stock split of its common stock at a ratio of up to 1-for-50,000 shares. The Company originally received shareholder approval to amend its Certificate of Incorporation to authorize a reverse stock split at.